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Abstract
Congenital nasolacrimal duct obstruction (CNLDO), previously considered a 
benign disease, affects 20% of the children globally. It is described by a collection of 
symptoms in which continuous epiphora and intermittent discharge are present in 
either one or both the eyes. CNLDO usually resolves in most healthy infants in the 
first few couple of months; however, it may persist for a number of years in some 
children. There has been a lot of recent deliberation on how a constant watery eye 
affects the visual development during the phase of emmetropization in children. A 
connection between CNLDO and anisometropia has been hypothesized. Multiple 
factors which include developmental and environmental aspects are thought to play 
a contributory role in the development of anisometropia by and large; particularly 
hypermetropic anisometropia, raising the chances of developing amblyopia in 
children with CNLDO. Published literature on CNLDO had shown inconclusive 
evidence on this anecdotal propinquity. This chapter discusses CNLDO; etiology, 
pathogenesis, treatment modalities, surgical intervention, and its role in inducing 
refractive errors; and its propensity to cause amblyopia.
Keywords: congenital nasolacrimal duct obstruction, anisometropia,  
refractive status, amblyopia
1. Introduction
Tears are words that need to be written (Paulo Coelho). Tears physiology and 
fluid dynamic are intricate and multifaceted. Tears are produced by the main and 
accessory lacrimal glands and drain medially into the puncta, then flow through 
the canaliculi to the lacrimal sac, and then through the nasolacrimal duct (NLD) 
into the nose. Contraction of the orbicularis muscles creates a pumping action that 
facilitates the flow of tears through the lacrimal system. Congenital nasolacrimal 
duct obstructions (CNLDO) are one of the most common cases seen in pediatric 
ophthalmology clinics. CNLDO occurs in 5–15% of full-term newborns [1]. 
CNLDO is characterized by epiphora and intermittent discharge. CNLDO remains 
the most common cause of epiphora in infants. It is usually unilateral or asymmetric 
and is largely due to a persistent membrane at the level of Hasner valve. The valve 
of Hasner is located at the distal end of the nasolacrimal duct where it enters the 
inferior meatus lateral to the inferior turbinate.
The valve of Hasner obstruction occurs due to unfinished canalization, a process 
that begins in the 12th week of gestation and is completed by the 24th week. An 
incidence of 35–73% has been reported for imperforate NLDs in full-term infants, 
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with a preponderance opening up spontaneously during the first couple of weeks 
of life [2]. The nasolacrimal duct normally canalizes from proximal to distal, so 
the distal portion is often last to open up. Therefore, premature infants conceiv-
ably have higher rates of CNLDO. However, because tear production does not 
take place almost near term, these infants mostly do not exhibit the symptoms of 
epiphora. Infants with CNLDO present with excessive tearing or mucoid discharge 
from the eyes due to blockage of the nasolacrimal duct system, which can result in 
maceration of the of the eyelid skin and local infections. On examination, there is 
an increased tear meniscus and there may be stickiness or crusting on the lashes. 
Secondary infection is common in CNLDO due to the stasis of lacrimal sac contents, 
proximity of the sinuses, and a rich lymphatic and vascular system within the 
submucosa of the lacrimal sac.
2. Initial assessment
It is important to note that typically, CNLDO does not usually cause much 
discomfort to children. Affected infants are otherwise well and act normally 
despite the presence of noteworthy overflow of tears and mucopurulent discharge. 
If infants have photophobia or other signs of chronic irritation, they should be 
checked carefully for signs of glaucoma, keratopathy, or epiblepharon, i.e., other 
factors of pediatric epiphora must be ruled out. The absence of corneal and 
conjunctival abnormalities is an important factor in establishing a diagnosis of 
CNLDO. Other causes of epiphora such as acute conjunctivitis, congenital anoma-
lies of the upper lacrimal drainage system (punctal or canalicular atresia or agene-
sis), entropion, and triachiasis also must be evaluated. The most important entity in 
the differential diagnosis of CNLDO/epiphora would be infantile glaucoma. NLDO 
may be confused with glaucoma by primary care physicians due to the presence of 
epiphora. It is important to check intraocular pressure, corneal diameters, and cup 
to disk ratio to rule out this condition.
It is recommended to do a fluorescein disappearance test (FDT) on all children 
with epiphora as it provides evidence to support a diagnosis of lacrimal outflow 
obstruction. Fluorescein 1% is instilled into each lower conjunctival fornix. The 
child sits on the parent’s lap while the cobalt blue light of a slit lamp is used to 
illuminates the eyes. Cobalt blue light of an ophthalmoscope can be alternatively 
used. The tear meniscus is evaluated at 2, 5, and 10 minutes. Each eye is graded at 
0, 1, 2, or 3 (0 = fluorescein completely gone, 3 = no fluorescein gone). Normally, 
the fluorescein disappears by 5 minutes but the dye remains in the conjunctival 
cul-de-sac in children with obstruction. Mild pressure on the lacrimal sac produces 
regurgitation of fluorescein-stained tears, particularly in those with a mucocele. 
This test visibly demonstrates the nature of the problem to the parents and provides 
practical time to discuss the cause and management of CNLDO. The fluorescein dye 
disappearance test can reliably confirm lacrimal duct obstruction noninvasively, 
with a sensitivity of 90% and a specificity of 100% [3]. In most centers, FDT has 
become the preferred tool for diagnosis of CNLDO.
Approximately 90% infants with CNLDO experience spontaneous resolu-
tion before the age of 1 year. It becomes symptomatic in merely 5–6% of infants 
[4]. Probabilities of spontaneous resolution by 12 months of age are 80–90%, 
at 3 months of age, 68–75%, at 6 months of age, and 36–57% at 9 months of age 
[5]. Bilateral symptoms are present in 14.0–33.8% of patients with CNLDO, all 
of which either spontaneously resolve simultaneously or within 3 months of 
contralateral resolutions. In cases of bilateral CNLDO, when epiphora in one eye 
settles spontaneously during 10–12 months of ages, it is rational to monitor the 
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child for further 3 months as spontaneous resolution can occur in a substantial 
percentage of children after 1 year of age [6].
Congenital dacryocystoceles are an uncommon variant of CNLDO, typically 
seen at birth or shortly after birth as a blue-colored cystic mass over the lacri-
mal sac. The valve of Hasner again is the most frequent site obstruction due to 
incomplete canalization. A congenital dacryocystocele accompanies CNLDO in 
approximately 0.1% of infants. Children with Down syndrome, craniosynostosis, 
Goldenhar sequence, clefting syndromes, hemifacial microsomia, and midline 
facial anomalies are at an increased risk for CNLDOs. Although most cases of 
CNLDO are diagnosed clinically, some conditions especially craniofacial malforma-
tions or Down syndrome, the bony obstruction at the CNLDO can be confirmed 
with computed tomography (CT Scans). Dacryocystocele (where both proximal 
and distal lacrimal system are obstructed) commonly results in dacryocystitis (or, 
rarely, neonatal respiratory obstruction) at birth, it necessitates surgical interven-
tion following diagnostic imaging.
3. Initial Management
The treatment of CNLDO is, at first, conservative. Conservative treatment con-
sists of nasolacrimal massage, warm compresses, and topical antibiotics for second-
ary infections. Massage of the lacrimal sac increases the hydrostatic pressure within 
the sac thereby breaking open the distal membrane. The most important aspect 
of conservative treatment is educating the parents, providing reassurance and 
information about the etiology, and natural history of CNLDO. Printed leaflets that 
provide information for the parent are very useful. Parents should be encouraged 
to clean the lids and lashes with cooled boiled water or normal saline and to lightly 
express the contents of the lacrimal sac. This maintains flow in the system and 
prevents stagnation, reducing any sticky discharge. Method of the massage should 
be explained to the parents. Parents find this difficult and need clear instructions. 
They should press on the sac below the medial canthus with their little finger 
multiple times per day if possible. Vaseline or liquid paraffin should be applied to 
the periocular skin to protect and treat any areas of redness or broken skin.
Antibiotic eye drops in CNLDO should only be used when it is accompanied 
by signs of conjunctivitis. It is somewhat common practice in some centers 
that topical antibiotics are used in combination with conservative therapy for 
CNLDO. However, there is no evidence indicative of the fact that antibiotic eye 
drops appreciably facilitates the resolution of CNLDO. Conjunctival bacterial flora 
in CNLDO patients is almost identical to those in the normal pediatric population 
and the use of antibiotic eye drops may cause normal bacterial flora to be substi-
tuted with a drug resistant flora. As infants have immune system that is in flux and 
is not geared-up to remove resistant bacteria they may possibly become carriers of 
resistant bacteria. Thus, antibiotic eye drops are completely unnecessary in conser-
vative therapy for simple CNLDO [7].
3.1 Surgical management
Intervention is usually done when CNLDO becomes persistent and/or once 
the child is older than 1 year of age. Probing the nasolacrimal duct to open the 
membranous obstruction at the distal nasolacrimal duct is the preferred initial 
management. Probing can be performed without anesthesia in the office setting, 
but it is usually preferred to do the procedure under general anesthesia (GA) in the 
operating room. The benefit of GA is less discomfort and the ability to perform 
Frontiers in Ophthalmology and Ocular Imaging
4
additional procedures if other abnormalities are found while the child is under 
GA. Probing aims to solve the symptoms of epiphora/discharge by clearing up the 
membranous obstruction; however, it may not be able to relieve the obstruction if it 
is due to protrusion of the bone of inferior turbinate into the NLD or when the NLD 
is swollen due to inflammatory processes such as dacryocystitis. Moreover, probable 
complications with probing are; false passage formation, injury to the NLD, puncta, 
canaliculi, bleeding, laryngospasm, and rarely aspiration.
While obstruction is mostly located at the valve of Hasner, obstruction may be 
anywhere along the route. Surgical intervention consists of the introduction of a 
flexible metal probe into the nasolacrimal duct to open it. A probe is placed into the 
nasolacrimal duct and passed into the nose. Following probing the nasolacrimal 
system is irrigated to assess its patency. This is usually done with normal saline 
tagged with fluorescein dye. If fluorescein dye can be picked-up by suction from 
the pharynx, probing can be considered successful. Postoperative tobramycin-
dexamethasone eye drops are used four times a day for 2–3 weeks. If after 6 weeks, 
there is no improvement in signs or symptoms, probing and syringing (P&S) can be 
repeated. Endoscopic inspection with a nasal scope during P&S is recommended; 
especially if it is being done the second time, to identify anatomical anomalies 
and to ensure accurate probe configuration. Various studies show a success rate of 
90–95% after initial probing [8–11].
The timing of initial probing is debatable and varies between surgeons and 
centers. Some surgeons recommend early intervention. Their concern is that pro-
longed epiphora is annoying to both child and parents. More importantly, a delay in 
treatment may increase the risk of infections and long-term damage to the system 
resulting in inferior success rates of simple probing. In countries where pediatric 
ophthalmic care is limited to a few urban centers; where children present late with 
complex CNLDO and where there is a high probability the child will not show up 
for a follow-up, an early probing can be justified to some extent.
Typically, it is thought that the older the child at the time of probing, the less 
successful the probing will be. Studies have reported variable success rates of prob-
ing and syringing when done in older children. A success rate of 94% was reported 
by Havins and Wilkins for probing done in children less than 8 months compared 
to 56% in children age 18 months and older [12]. Sturrock reported 86% success 
when probing was done in children less than 1 year compared to 72% between 1 
and 2 years of age and 42% for more than 2 years of age [13]. Katowitz and Welsh 
reported success rates of 76.4% in 13–18 month old children; however, the cure rates 
fall to 33.3% in children over 2 years [9].
Mannor et al. found a negative association between the age and success rates 
of P & S. Contrary to this, Robb, Zwaan, and El-Mansoury found more than 90% 
success rate in late as well as very late probing [10, 14, 15]. Robb found no difference 
in cure rate with increasing age and noted an overall success rate of 92% varying 
from 88.9 to 96.8% at different age intervals up to and beyond 3 years of age [16]. 
Honavar reported a success rate of 75.0% up to 4 years of age, after which it fell to 
42.9% in children older than 4 years [17]. Casady reported success rates of 85% for 
probing in children more than 18 months of age [18].
Factors besides increasing patient age that are associated with decreased 
success rates for probing are severe symptoms, bilateral symptoms, canalicular 
stenosis, atonic sac, and non-membranous CNLDO. A recent Cochrane review 
assessing the effects of probing for CNLDO showed that the effects and cost of 
immediate versus deferred P & S for CNLDO are uncertain. Patients with uni-
lateral CNLDO may have improved success from immediate P & S in the clinic. 
Limiting factors in these studies were; sample sizes of participated children in 
these trials were small and researchers examined outcomes at different points in 
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time. They conclude that deciding whether to perform the procedure and its best 
possible timing will entail well-run clinical trials [19].
If the preliminary probing and syringing fails, one may perform; as discussed 
before, a secondary probing or an additional procedure. Second probing can 
be repeated four to six after the initial procedure. Cure rates of second probing 
are greatly decreased because unsuccessful first probing can result in cicatricial 
strictures or a false passage [20]. The two main secondary procedures are balloon 
dacryoplasty and silicone tube intubation.
During balloon dacryoplasty, a stent with a balloon at its distal end is passed 
into the distal nares, the balloon is inflated (usually couple of times), then deflated 
and removed. The aim is to widen the distal duct and decrease obstruction. The 
primary advantage of balloon dacryoplasty is that no stent material is left in the 
lacrimal system and therefore stent removal is not required. Balloon dacryoplasty is 
particularly useful for patients with diffuse stenosis of the distal NLD. Success rates 
for balloon dacryoplasty as a primary procedure are as high as 94%; however, the 
procedure is costly; nevertheless it may have its benefit in intractable cases [21, 22]. 
Furthermore, the role of balloon dacryoplasty in the management of CNLDO needs 
further evaluation and assessment.
Intubation is necessary in cases with lacrimal canalicular stenosis after probing. 
The silicone tube prevents the formation of granulation-related obstruction around 
the newly patent tract. Bicanalicular or monocanalicular silicone intubation of the 
nasolacrimal duct can be used as a primary or secondary procedure. Intubation 
should take place under GA after the nose has been prepared with decongestant. 
It is recommended that a nasal endoscopic guidance system is used to view the 
inferior meatus [23]. The lacrimal system should be probed first to ensure that the 
tubes have an anatomical passage. Tubes come with a metal introducer and one 
end should be placed through the system via the upper canaliculus, into the sac 
and down the nasolacrimal duct into the inferior meatus from where it should be 
retrieved under endoscopic view. The other end of the tube is inserted in exactly the 
same way through the lower canaliculus. The ends are tied securely with multiple 
square knots inside the nose and trimmed. Postoperative treatment consists of a 
topical antibiotic and steroid preparation for 2–3 weeks.
Possible complications of intubation include canalicular cheese-wiring, superi-
orly/inferiorly dislocation, infection, and scarring of any part of the nasolacrimal 
drainage system. Silicone tube stents if removed too early may result in the recur-
rence of obstruction. Breakage or prolapse of the tube may cause corneal abrasions 
[24]. Retrieval of the probe is sometimes difficult during intubation and during 
instrumental manipulation required during it may damage the nasal mucosa and 
turbinate [25]. The timing of removing the tube is contentious, but the suggested 
time is anywhere between 6 weeks and 18 months [26]. Leaving a tube in situ for 
about 6 months may attain better success rates compared to removing it earlier [27]. 
A study reports that early removal of tube in children younger than 2 years did not 
reduce the success rates of intubation [28]. Long-term intubation is associated with 
a higher occurrence of breakage, dislodgement, migration, dislocation, or prolapse. 
Tubes in almost all the cases are removed under GA through the nose. The tube is 
cut at the medial canthus and removed under direct vision to prevent aspiration of 
the tube. This system is then irrigated to remove any debris and to verify patency.
Its success rate of intubation range from 62 to 100% but in general, they decrease 
with increasing age [29, 30]. A study reported success rates for intubation stratified 
by patient age. The success rate for intubation in children aged 12–24 months was 
91.3%, which reduced to 85.5% in those aged 24–36 months and to 79.6% in those 
aged 36–48 months [31]. Several studies have explored the effectiveness of intuba-
tion as a main treatment modality in older subgroup of children because of the 
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decrease in success rates for late probing. Although the success rate was high; none 
of the studies included a control group.
The bicanalicular device has a silicone tube with a flexible metal probe on each 
end. Each separate end is introduced into the upper or lower punctum and then 
retrieved from the nose. Bicanalicular stents pass through both the upper and lower 
canaliculus and typically create a closed circuit. Bicanacular system intubates the 
upper and lower canaliculi connecting via the common canaliculus or the lacrimal 
sac thereby intubating the entire nasolacrimal drainage system with the circuit 
being open or closed in the nose. Examples of Bicanacular stent include Crawford 
stent, Ritleng stent, Pigtail/Donut stent, and Kaneka Lacriflow stent.
Monocanalicular stents do not provide a closed loop system, but only intubates 
either the upper or lower canaliculus. Examples of monocanalicular stents include 
Monoka Stent and Jones Tube. Both monocanalicular and bicanalicular intuba-
tions are effective methods for treating CNLDO. Monocanalicular intubation has 
the advantage of a lower incidence of canalicular slit formation, technical ease of 
insertion, and easier tube removal. Moreover, the tubing does not threaten the un-
probed part of the lacrimal drainage system [32]. Bicanalicular intubations may be a 
better treatment for the patients with incomplete complex CNLDO [33].
A met-analysis in 2016 showed that the results of immediate and deferred P & S 
did not vary in their success rates. There was no difference in between the success rates 
of balloon dilation and intubation. Monocanalicular and bicanalicular intubation had 
similar success and dislocation rates. Therefore, the preference of a particular proce-
dure on the treatment of CNLDO should be discussed in detail with parents by the 
concerned surgeon to achieve the best possible results [34].
In cases where all above measures fail or in complex CNLDO, some surgeons 
perform additional procedures such as turbinate fracture or dacryocystorhinostomy 
(DCR). DCR is done provided the obstruction is distal to the lacrimal sac. DCR rep-
resents a last resort for patients in whom; multiple procedures have failed, complex 
CNLDO, or in whom there is obstruction secondary to bony obstruction, dacryo-
cystitis, dacryocystocele, older children, or craniofacial dysmorphism. Infracture 
of the inferior turbinate, usually done with a periosteal elevator or a hemostat, 
is used to decrease the resistance of drainage in the distal nasolacrimal duct. It is 
mostly useful for patients who have an exceedingly tight space between the inferior 
turbinate and nasal wall. It also allows for better visualization of the inferior meatus 
during endoscopic surgery. The success rate of inferior turbinate fracture alone is 
83% [35]. Although a combination of probing with intubation results in good cure 
rates of 88–100%, the success rate for a combined inferior turbinate fracture and 
probing is no different to that for simple probing [36].
Conventional/external DCR is carried out through skin incision, the lacrimal 
sacs are exposed, an osteotomy is made through the nasal bone, flaps are created 
between the lacrimal sac and the nasal mucosa and then tube is placed which serves 
as a stent. Laser DCR is a substitute; the ostium is created by means of a laser which 
is placed through the canaliculus just adjacent to the nasal bone. An endoscope is 
mostly used during laser DCR. Nasolacrimal stents are placed at the end of the pro-
cedure. External and endoscopic DCR have excellent success rates, comparable to 
those of adult DCRs [37]. Endoscopic DCR can avoid a cutaneous scar and disrup-
tion of the medial canthal anatomy, but a pediatric endoscopic DCR is technically 
more demanding because of the poor visualization afforded by small nostrils and 
closer proximity of the operative field to the base of the skull [38].
Pediatric DCR has high success rates of 88–96% for external DCR and 82–92% 
for endoscopic DCR [39]. Rapidly altering anatomy, ill-defined anatomical land-
marks, and aggravated growth of scar tissue have been suggested as possible factors 
that could influence surgical outcomes in pediatric DCR. On top, because of a 
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narrowed nasal cavity there is a propensity toward development of postoperative 
adhesions between the rhinostomy site and the nasal septum; the use of a silicone 
tubes in pediatric DCR may avert this obstruction and consequently ensure better 
surgical outcomes [40].
4. CNLDO and its effect on the visual system
CNLDO has long been considered as a benign condition that does not influence 
visual development. CNLDO has been at the hub of current debate on its proposed 
relationship with anisometropia, strabismus, and amblyopia. The persistent tearing 
caused by CNLDO distorts retinal images by producing a blur, thus defocusing the 
retinal image thereby adversely influencing the process of physiological emme-
tropization. This interference with the physiological emmetropization has possibly 
led to frequent findings of anisometropia in various studies.
The role of focused retinal images in the physiological emmetropization has 
been discussed by Wright [41]. Newborns are hyperopic having a short axial length 
relative to the refractive power of the cornea and lens. During the first few months 
of life rapid growth in axial length (AL) occurs with subsequently decreases the 
hypermetropia. The retinal image comes in clear focus through “emmetropization.” 
Various studies have shown that growth of the eye after birth and the development 
of its refractive capabilities are dependent on vision-dependent retinal mechanisms. 
A basic observation is that a continuous image blur on the retinal cells in a new born 
can result in lengthening of the axial length thus inducing myopia. The axiom is 
that when we are born the AL of the eye is short; therefore, the eye is hypermetropic 
and image blur on the retinal tissue in early life kindles AL elongation until image 
clarity is achieved by proper focusing of light rays. Raviola and Wiesel concluded 
that when visual input is deprived, as seen in cases where there is a dense corneal 
opacity or ptotic/closed eyelids, the eye has a tendency toward myopia [42]. Even 
if the eyelids are completely closed, more than 20% of light is still passed on to the 
retina [43]. The influence of a blur images is so immense that (in a study done on 
chicks) if only half the retinal image is blurred, then only that half of the globe will 
lengthen [44].
In comparison to blurred images, if there is no stimulation of light, studies 
show that it slows down the progress of blurred induced myopia and AL elonga-
tion. In theory, clearing up the image blur would abolish the stimulus of image 
blur on AL elongation, thereby retarding AL growth and the process of emme-
tropization, thereby causing hypermetropia [45]. In addition to the influence of 
AL elongation by blurred image stimulation of the retina, it seems that intrinsic 
growth of the eye is disengaged from visual input. AL elongation and thickness 
of the choroid alterations occur in diurnal pattern. In general, AL elongates and 
choroid thickens during the day and dawdle downs at night signifying a circadian 
rhythm. This suggests that the eye has an intrinsic growth rate that will occur in 
the absence of visual input [46].
No cause-effect relationship linking CNLDO and anisometropia has been stud-
ied and the precise method by which CNLDO might cause refractive error, aniso-
metropia, and amblyopia is indistinct. As discussed, the proper focusing of images 
on the retina early in life is vital for emmetropization. It is indefinite what part, if 
any; persistent tearing has on visual development, refractive status, and amblyopia. 
Several authors have recently described an association between CNLDO and the 
development of amblyopia and strabismus secondary to anisometropia [47–49]. 
The major visual concern in CNLDO is the presence of significant anisometropia 
during vital period of visual development in these infants.
Frontiers in Ophthalmology and Ocular Imaging
8
CNLDO rarely, if ever, results in complete visual obstruction. Besides, early 
unilateral visual deprivation as discussed before has been linked with myopia not 
hypermetropia [42, 50]. It is postulated that accumulation of discharge, excessive 
tears, and antibiotic ointments may result in deformation of retinal images. This 
image disparity may lead to a lack of appropriate emmetropization process and as a 
result the repeated finding of anisometropia in the affected eye. It is also proposed 
that this anisometropia is refractory. However, recent studies reveal that this is not 
necessarily true [51], which will be discussed in a while.
4.1 Visual system, anisometropia, and amblyopia
An estimated 285 million people around the world are visually impaired; 19 
million are children below the age of 14 years. Childhood visual impairment is 
estimated to be the second leading cause of the burden due to blindness [52]. Forty 
percent of childhood blindness is preventable; 12 million children are visually 
impaired merely because of refractive errors. Uncorrected refractive errors lead 
to amblyopia and strabismus [53, 54]. Anisometropia is one of the major causes of 
amblyopia. Visual disabilities in children are also more intricate compared to adults 
thus preventing visual impairment in children in resource-poor countries is one of 
the key components of VISION 2020 the Right to Sight.
The significance of anisometropia as a source of amblyopia is well documented. 
Amblyopia risk factors based on American Association for Pediatric Ophthalmology 
and Strabismus (AAPOS) criteria include: anisometropia (spherical or cylindrical) 
>1.5 diopters; any manifest strabismus; hypermetropia >3.5 diopters in any merid-
ian: myopia magnitude >3.0 diopters in any meridian: any media opacity >1 mm; 
astigmatism >1.5 diopters at 90 or 180° >1.0 diopters in oblique axis (more than 10° 
from 90 or 180°) and ptosis ≤1 mm margin reflex distance (MRD) [55]. Although 
binocular single vision (BSV) develops at the age of 2 years, the fixation reflex is 
not fully established until the age of 9 years. Visual acuity remains in a state of flux 
prior to this age predisposing the child to anisometropia, strabismus, and amblyo-
pia. In a population-based study on 961 children with amblyopia, the author found 
the cause to be strabismus in 57%, anisometropia in 17%, and combination of two 
in 27% patients [56].
Donahue suggests that 1D of anisometropia can be considered as clinically sig-
nificant anisometropia [57]. Nevertheless due to individual physiologic variability’s, 
amblyopia can even be seen with milder degree of anisometropia. The prevalence 
of anisometropia in the general pediatric population ranges from 2.3 to 3.4%, based 
on literature review [58]. Amblyopia has been reported to occur in approximately 
1.6–3.6% of the normal population [51, 58]. The prevalence is even higher in medi-
cally underserved populations with reported rate as high as 22.7% [59]. The popu-
lation-based Multi-ethnic Pediatric Eye Disease Study found that 78% of African 
American and Hispanic children had amblyopia which was traced back to be due to 
anisometropia [60]. A population-based Baltimore Pediatric Eye Disease Study was 
conducted on the White and African-American Children. This study concluded that 
32% of cases of amblyopia were attributed to anisometropia [61].
Studies on the prevalence of anisometropia (greater and equal to 1D between 
two eyes) reveal that 2.3–3.4% of pediatric population aged 5–11 years is affected 
[62, 63]. Drover et al. showed the prevalence of anisometropia to be at 1.4% in the 
studied pediatric population (mean age 4.2 years) [64]. Huynh et al. study con-
ducted in Sydney, concluded an anisometropic prevalence of 1.6–2.4% (mean age 
6.7 years) [65]. Shih and colleagues conducted a population survey in Taiwan and 
found an anisometropic prevalence ranging from 7.2 to 9.3% in older children (age, 
7–18 years) [66]. Studies show that anisometropia is an identifiable amblyogenic 
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factor in 37% of cases and present concurrently with strabismus in an additional 
24% of clinical populations [67].
Apart from refractive errors, a variety of risk factors increase the likelihood 
of amblyopia. A study showed that 28.7% of children whose parents had known 
strabismus were also found to have strabismus, a known amblyopia risk factor; this 
suggests a hereditary risk factor [68]. Low birth weight (<2499 g) and severe mental 
handicap are established risk for developing amblyopia [69]. Further risk factors 
include capillary hemangiomas of the eyelids, ptosis, blepharophimosis, craniosyn-
ostosis, and hydrocephalus. Socioeconomic factors also increase the risk of develop-
ing amblyopia. Children from underprivileged background, such as homeless kids 
and those coming from homes where either parents smoke, have a high prevalence 
of amblyopia [70, 71].
Amblyopia is clinically significant because it is one of the main causes of visual 
loss in children. Amblyopia is also of central interest because it suggestive of 
diminished neuronal activity that occurs when normal visual growth is interrupted. 
Amblyopia affords an idyllic template for understanding when and how a plastic 
brain may be used for functional recovery. Impaired stereoscopic depth perception 
is the most common deficit associated with amblyopia under ordinary binocular 
viewing conditions. This impairment may have a substantial impact on visuomotor 
tasks and difficulties in playing sports in children. Furthermore, impaired stere-
opsis may also limit career options for amblyopes. Stereopsis is more affected in 
strabismic than in anisometropic amblyopia. Recovery of stereoacuity may require 
more vigorous treatment protocols in strabismic than in anisometropic amblyopia. 
Individuals with strabismic amblyopia have a very low probability of improvement 
with monocular training; however, they get on well with dichoptic training (prom-
ising new therapeutic approach to amblyopia, which employs simultaneous and 
separate stimulation of both eyes) than with monocular training and much better 
with direct stereo-training [72, 73].
Thus, Anisometropia primarily disturbs binocularity thereby causing reduced 
stereoacuity. Development of stereoacuity is interrelated to similarity in the refrac-
tive status of the fellow eyes; fine motor skills which require swiftness and precision 
of movements are defective in amblyopic children. Therefore, management of 
anisometropic amblyopia is more prolonged and complex, especially if it is accom-
panied with strabismus [74]. In distinction to strabismic and deprivational amblyo-
pia, anisometropic amblyopia is more frequently asymptomatic and detected at an 
older age; only 15% of affected children are diagnosed before they are 5 years of  
age [75].
Studies demonstrate that the most important factors in treatment results are 
age and depth of amblyopia that are directly related to the degree of anisometropia 
[76]. Therefore, as the child gets older, management becomes more complex and 
time consuming particularly in hypermetropic anisometropes in whom a less 
encouraging treatment results are seen, in contrast to myopes. It is suggested that 
in anisometropic subjects, amblyopia is less severe in children younger than 3 years 
of age and improvement in visual and stereoacuity is more probable if treatment 
is initiated prior to this age [77, 78]. Based on repeated finding of anisometropia in 
CNLDO particularly in unilateral anisometropia it is vital to check refractive status 
of children with CNLDO to assess visually significant anisometropia at an early age 
to prevent these children from amblyopia and visual morbidity.
4.2 CNLDO, anisometropia, and amblyogenic potential
First Chalmers and later Ellis questioned the relationship between CNLDO and 
visual maturation. Chalmers found anisometropia in 3.8%, in eyes with CNLDO; all 
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their subjects were hypermetropic in the affected eye [79]. Ellis found no apprecia-
ble increased incidence of amblyopia (1.6%) in a large series of 2249 patients with 
NLDO compared with controls. They also found no correlation between refractive 
error and NLDO, including no significant increase in the incidence of anisometro-
pia [80].
In our study, the prevalence of anisometropia (greater than 1.5 D) in NLDO 
patients of 13.7% is approximately thrice that of the general population [81]. It is 
also higher than reported studies on this subject matter [47, 48, 79–81]. Similarly, 
a study of around 1200 CNLDO patients found twice the rate of anisometropia 
in the unilateral CNLDO patients (7.6%) compared with bilateral NLDO patients 
(3.6%) that the rate of anisometropia and amblyopia is greater in NLDO patients. 
Anisometropia occurred at a greater rate in unilateral NLDO patients compared 
with bilateral NLDO patients and occurred at a greater rate in this CNLDO cohort 
than expected in the general pediatric population. Several patients with anisome-
tropia went on to develop clinical amblyopia [47].
Matta et al. reviewed 375 patients with CNLDO and reported that 22% of the 
children with CNLDO had amblyopia risk factors [48]. Piotrowski and colleagues 
described a high prevalence (9.8%) of anisometropia with or without amblyopia in 
an 8-year consecutive case series which included 305 children with CNLDO [49]. 
Furthermore, Eshraghi and colleagues studied 433 cases with CNLDO that under-
went probing. They reported that 5.5% had anisometropia and 9.46% had amblyo-
pia risk factors. They also found more anisometropia in failed probing cases and 
theorized that structural abnormality may have a part to play in the development of 
anisometropia [82].
Bagheri et al. evaluated refractive state in children with unilateral CNLDO; they 
reported that in children aged 4 years and older, the interocular difference between 
spherical error and spherical equivalent was considerable as compared to children 
younger than 4 years [83]. Contrary to this, in our study, we found no significant 
association between the age (in months) of the patients and the interocular differ-
ence in sphere, cylinder, and SE of affected and non-affected eyes. However, when 
we observed the refractive status of children with CNLDO, we found that as the 
children age increased the prevalence and severity of refractive error and anisome-
tropia increased. We also observed that difference between the affected and fellow 
eyes was significant in terms of spherical refractive error and spherical equivalent 
and that hypermetropia was more common in the eye with CNLDO. These findings 
illustrate that when unilateral CNLDO becomes chronic, the likelihood and severity 
of hypermetropia increases which as detailed, is a risk factor for amblyopia [81, 84]. 
This finding is clinically significant, as management and prognosis of amblyopia 
becomes intricate in older children.
The published literature proposes that the prevalence of anisometropia increases 
as the nature of the CNLDO becomes more chronic. Our study on bilateral CNLDO 
shows that the interocular difference in the mean spherical equivalent of children 
with unilateral CNLDO increases with the age of the patients. This was not the case 
in the patients with bilateral CNLDO. Therefore, children with chronic obstruction 
are more prone to be amblyogenic [85]. Hence, timely resolution of the problem is 
recommended to avoid visual morbidity, i.e., anisometropia and amblyogenicity.
If the anticipated association between CNLDO and anisometropia is refractory 
and the persistent epiphora, discharge, and topical medication in the conjunctival 
cul-de-sac is being held responsible in hampering the physiological emme-
tropization, then early resolution of CNLDO should retard the development of 
anisometropia and thus save the child from developing anisometropic amblyopia. 
However, a study found results contrary to this. Recently, Pyi Son studied 244 
cases and found that early and spontaneous resolution of CNLDO is more likely 
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to have a higher (not lower) rate of anisometropia compared to spontaneous or 
surgical resolution [86]. They proposed that the eye with CNLDO proceeds to 
emmetropization differently than the unaffected eye. Early resolution can hinder 
the process of emmetropization in the affected eye, making it lag behind the 
normal eye in achieving emmetropization. These findings negate the fact that 
anisometropia in CNLDO is transient and refractory. Further studies need to be 
done to determine the timing of resolution of CNLDO and its effect on the devel-
opment, progression, and resolution of anisometropia and if present amblyopia. 
In most studies, including the one we conducted, they did not determine whether 
anisometropia persisted or not after surgical intervention or in later life. Simon 
reported that even after CNLDO has improved, anisometropic hypermetropia is a 
regular finding in patients with a history of unilateral CNLDO [87]. Nevertheless, 
results of all these studies consistently report high rates of anisometropia which 
concomitantly has amblyogenic effect.
Even though studies suggest that correction of the refractive error in aniso-
metropia alone results in enhances quality of vision in anisometropic amblyopia, 
it is usually contemplated that most of cases will need added treatment because 
refractive error adjustment alone will not be adequate to completely manage the 
depth of amblyopia. Therefore, patching or pharmacological treatment is often 
prescribed at the same time or soon after the refractive spectacle correction is 
given. Concrete evidence, generally from the Pediatric Eye Disease Investigator 
Group, has established both number of hours per day of patching (according 
to age) and days per week of atropine use as good penalization technique to 
improve vision and stereoacuity in amblyopia [88]. The use of glasses alone has 
also been recognized as an excellent first-line treatment for both anisometropic 
and strabismic amblyopia. IPad-based dichoptic training has shown promising 
data for vision rehabilitation in amblyopes. Use of pharmaceutical augmentation 
of traditional therapies has also been investigated. Several different drugs with 
unique mechanisms of action are thought to improve the receptiveness to amblyo-
pia therapy. However, no data on new treatment options from evidence-based 
research has surfaced which proves as being better to conventional therapies in 
regular clinical practice. Continued research into the use of new technology and 
comprehending the neuronal basis of amblyopia promises alternate or perhaps 
improved cures in the near future [89].
Studies mention that emmetropia is achievable in anisometropes with appropri-
ate management [90]. However, the precise cause why studies find high prevalence 
of anisometropia in subjects even after CNLDO has resolved is still contentious. 
Nevertheless, the results endorse the fact that patients of CNLDO should be 
regularly reviewed for refractory status. Furthermore, as shown in our results, in 
older subjects, the interocular difference becomes more significant compared to 
younger children; this places them at high risk for developing amblyopia. They 
are also inclined to poor prognosis in terms of visual recovery. These facts support 
the benefit of early intervention in CNLDO. However, further studies with larger 
sample size longer follow-up time is required to establish this effect.
5. Conclusion
CNLDO should be observed and treated conservatively till the child is 1 year 
old. If CNLDO does not respond to conservative treatment, then they should 
be promptly treated with probing and syringing. In cases remission two cycles 
of syringing and probing, intubation is a reasonable treatment option. Surgical 
procedures should be reserved for complicated cases. Unilateral CNLDO is a 
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risk factor for anisometropia particularly hypermetropic anisometropia with 
amblyogenic potential. Keeping in view that CNLDO is a common presentation 
in pediatric ophthalmology clinics, we recommend that all children with CNLDO 
should be regularly followed, even after the obstruction has anatomically and 
functionally resolved. These children should undergo cycloplegic refraction on each 
visit and should be monitored for the development of amblyopia and other ocular 
abnormalities.
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